Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China

Triple Therapy with Interventional Treatment, Donafenib, and Anti-PD-1 Antibodies in Unresectable Hepatocellular Carcinoma: A Retrospective Real-World Study in China

Qiuwen Ye,1,* Zhengrui Song,1,* Tingdong Yu,1 Yong Li,1 Liang Ai,1 Guangjun Yang,2 Kun Su,3 Dong Chen,4 Wentao Zhao,5 Rong Ding,6 Yong Zha,1 Gang Li1 1Department of Hepatobiliary and Pancreatic Surgery, Yunnan Cancer Hospital, Kunming, Yunnan, People’s Republic of China; 2Dep...

Full description

Saved in:
Bibliographic Details
Main Authors: Ye Q, Song Z, Yu T, Li Y, Ai L, Yang G, Su K, Chen D, Zhao W, Ding R, Zha Y, Li G
Format: Article
Language:English
Published: Dove Medical Press 2025-08-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
Hepatocellular carcinoma
Donafenib
tyrosine kinase inhibitors
interventional therapies
immune checkpoint inhibitors  
Online Access:https://www.dovepress.com/triple-therapy-with-interventional-treatment-donafenib-and-anti-pd-1-a-peer-reviewed-fulltext-article-JHC
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/triple-therapy-with-interventional-treatment-donafenib-and-anti-pd-1-a-peer-reviewed-fulltext-article-JHC

Similar Items